The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.Yuanbo Liu(Capital Medical University)Research SquareNovember 18, 202110.21203/rs.3.rs-793020/v1Cited by 1SaveCiteExport RISWatch citationsRelated PapersThe PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis|BMC Cancer|2022|33Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma|Oncology Reports|2016|18